301 related articles for article (PubMed ID: 11245482)
1. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
[TBL] [Abstract][Full Text] [Related]
3. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
4. PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells.
Novellino L; De Filippo A; Deho P; Perrone F; Pilotti S; Parmiani G; Castelli C
Cell Signal; 2008 May; 20(5):872-83. PubMed ID: 18276111
[TBL] [Abstract][Full Text] [Related]
5. Regulation of VE-cadherin linkage to the cytoskeleton in endothelial cells exposed to fluid shear stress.
Ukropec JA; Hollinger MK; Woolkalis MJ
Exp Cell Res; 2002 Feb; 273(2):240-7. PubMed ID: 11822879
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
[TBL] [Abstract][Full Text] [Related]
7. Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence.
Takahashi K; Suzuki K; Tsukatani Y
Oncogene; 1997 Jul; 15(1):71-8. PubMed ID: 9233779
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 gene product associates with catenins in human cancer cells.
Ochiai A; Akimoto S; Kanai Y; Shibata T; Oyama T; Hirohashi S
Biochem Biophys Res Commun; 1994 Nov; 205(1):73-8. PubMed ID: 7999105
[TBL] [Abstract][Full Text] [Related]
9. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
Kim K; Daniels KJ; Hay ED
Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103
[TBL] [Abstract][Full Text] [Related]
11. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
12. Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin.
Balsamo J; Leung T; Ernst H; Zanin MK; Hoffman S; Lilien J
J Cell Biol; 1996 Aug; 134(3):801-13. PubMed ID: 8707857
[TBL] [Abstract][Full Text] [Related]
13. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells.
Hiscox S; Jiang WG
Biochem Biophys Res Commun; 1999 Aug; 261(2):406-11. PubMed ID: 10425198
[TBL] [Abstract][Full Text] [Related]
14. Loss of density-dependent growth inhibition and dissociation of alpha-catenin from E-cadherin.
Tsukatani Y; Suzuki K; Takahashi K
J Cell Physiol; 1997 Oct; 173(1):54-63. PubMed ID: 9326449
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
Kim K; Lee KY
Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells.
Shibata T; Ochiai A; Kanai Y; Akimoto S; Gotoh M; Yasui N; Machinami R; Hirohashi S
Oncogene; 1996 Sep; 13(5):883-9. PubMed ID: 8806677
[TBL] [Abstract][Full Text] [Related]
17. The E-cadherin complex contains the src substrate p120.
Aghib DF; McCrea PD
Exp Cell Res; 1995 May; 218(1):359-69. PubMed ID: 7537697
[TBL] [Abstract][Full Text] [Related]
18. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
19. Turn-off, drop-out: functional state switching of cadherins.
Lilien J; Balsamo J; Arregui C; Xu G
Dev Dyn; 2002 May; 224(1):18-29. PubMed ID: 11984870
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
